Dosage Schedule Linked to Rate of PCV Breakthrough Infections Dosage Schedule Linked to Rate of PCV Breakthrough Infections
A dosing schedule that includes three primary doses of pneumococcal conjugate vaccine (PCV) is associated with fewer breakthrough infections in the first year of life than are schedules with two primary doses, according to a new study of surveillance data.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 15, 2020 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

Cincinnati startup licenses technology invented by renowned children ’s hospital
Blue Water Vaccines Inc., a Norwood startup, has entered into an exclusive worldwide license agreement with St. Jude Children ’s Research Hospital to develop a vaccine for Streptococcus pneumoniae. The bacteria can cause many kinds of diseases, including the lung infection pneumonia. “A major limitation of the currently licensed pneumococcal vaccines is the lack of efficacy against mucosal disease manifestations such as acute otitis media, acute bacterial sinusitis and pneumonia,” Blue Water… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 10, 2020 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Hexavalent Vaccine Included in Vaccines for Children Program
FRIDAY, Feb. 7, 2020 -- The hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenza type b (Hib) conjugate (meningococcal protein conjugate), and hepatitis B... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Pneumococcal vaccines are effective -- But new strategies needed to reduce meningitis
(Wolters Kluwer Health) Pneumococcal conjugate vaccines (PCVs) have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria. But rates of meningitis have shown little change, as pneumococcal strains not targeted by PCVs emerge as more important causes of meningitis, reports a paper in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2020 Category: International Medicine & Public Health Source Type: news

New research into how peace of mind can influence parents' attitude to vaccines
(Meningitis Research Foundation) Research from Bristol University on parents' peace of mind and vaccinations gives us insight that beliefs about vaccines can change, and that peace of mind varies according to different factors. The MenB vaccine, although considered 'new' provided increased reassurance because of the perceived disease severity. Meningitis Research Foundation says parents' peace of mind is currently being ignored when health bodies weigh up vaccine benefits to make decisions whether to introduce vaccines or expand their coverage. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 4, 2020 Category: International Medicine & Public Health Source Type: news

Updated Pneumococcal Vaccine Recommendations for Older Adults Updated Pneumococcal Vaccine Recommendations for Older Adults
What do the new PCV13 recommendations mean, and how do you implement them in your practice? Here's what you need to know.CDC Expert Commentary (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 31, 2020 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news

New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 31, 2020 Category: Consumer Health News Source Type: news

MenB vaccination programme evaluation
Public Health England has announced that the MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 29, 2020 Category: Consumer Health News Source Type: news

PNEUMOSIL ® , the new pneumococcal vaccine, achieves WHO...
Leaders from PNEUMOSIL® collaborators—the Serum Institute of India and the Bill & Melinda Gates Foundation—to speak at the first-ever Global Forum on Childhood Pneumonia on January 29-31,...(PRWeb January 28, 2020)Read the full story at https://www.prweb.com/releases/pneumosil_the_new_pneumococcal_vaccine_achieves_who_prequalification_a_key_step_toward_improving_access_and_affordability/prweb16866771.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 28, 2020 Category: Pharmaceuticals Source Type: news

New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: NHS Networks)
Source: NHS Networks - January 24, 2020 Category: UK Health Source Type: news

Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 20102018: A systematic review to inform national guidance in the UK.
Pneumococcal outbreaks are rare but they still occur, particularly in closed settings usually involving vulnerable groups. The authors undertook a systematic review to identify strategies for controlling pneumococcal outbreaks since the licensure of higher-valent pneumococcal conjugate vaccines (PCVs). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2020 Category: Consumer Health News Source Type: news

Erratum: Vol. 68, No. 46
In the report " Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices, " on page 1074... (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 2, 2020 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news

Kids With Asthma at Greater Risk for Pneumococcal Disease Kids With Asthma at Greater Risk for Pneumococcal Disease
Children with asthma were at increased risk for pneumococcal disease, even those who had been vaccinated, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2019 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Dr. John Robbins, Developer of a Meningitis Vaccine, Dies at 86
His method of boosting immune protection in babies helped save seven million lives. But he never profited from it. (Source: NYT Health)
Source: NYT Health - December 18, 2019 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: John B. Robbins Deaths (Obituaries) Vaccination and Immunization Inventions and Patents Children and Childhood Haemophilus influenzae type b (Hib) Food and Drug Administration National Institutes of Health Meningitis Source Type: news

Pneumococcal 13-valent polysaccharide vaccination (PCV13) response in patients with pulmonary aspergillosis
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 12, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

New Recommendations for Pneumococcal Vaccine in Older Adults New Recommendations for Pneumococcal Vaccine in Older Adults
Review recent changes in ACIP's recommendations for pneumococcal conjugate vaccine use in older adults.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 11, 2019 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news

Africa: Gavi Must Stop Giving Millions in Subsidies to Pfizer and Gsk for Pneumonia Vaccine
[MSF] New Delhi/New York -Gavi, the Vaccine Alliance should immediately stop giving millions of dollars in financial incentives to pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) for the pneumococcal conjugate vaccine (PCV), said the international humanitarian organization Doctors Without Borders/M édecins Sans Frontières (MSF) ahead of the group's board meeting in New Delhi, India on December 4 and 5. Instead, Gavi should use the remaining US $262 million of the US $1.5 billion subsidy fund to support the ro (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 4, 2019 Category: African Health Source Type: news

Chickenpox vaccine reactivates in two boys, causing rare meningitis more commonly seen in unvaccinated kids
Doctors described what they believe are the first known cases of meningitis due to reactivation of chickenpox vaccine in two 14-year-old boys who received both recommended doses, according to a paper published Wednesday in the journal Pediatrics. (Source: CNN.com - Health)
Source: CNN.com - Health - November 27, 2019 Category: Consumer Health News Source Type: news

Two teen boys become first ever to get meningitis from chickenpox shot 
A new paper has discussed the case of two 14-year-old boys who were diagnosed with meningitis after the chickenpox vaccine they received as children allegedly reactivated. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2019 Category: Consumer Health News Source Type: news

Eritrea: National Meningitis Vaccination Program Commences
[Shabait] Asmara -The National Meningitis Vaccination program and distribution of vitamin 'A' commenced today, 15 November in the presence of senior Government officials, representatives of UN offices in Eritrea and stakeholders. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2019 Category: African Health Source Type: news

CDC: PCV13 No Longer Routinely Recommended for Adults & #8805;65
THURSDAY, Nov. 21, 2019 -- The 13-valent pneumococcal conjugate vaccine (PCV13) is no longer recommended for routine use among adults aged ≥65 years, according to research published in the Nov. 22 issue of the U.S. Centers for Disease Control and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2019 Category: Pharmaceuticals Source Type: news

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
Pneumococcal conjugate vaccine use in children has led to sharp declines in pneumococcal disease among adults and children. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 21, 2019 Category: American Health Tags: Immunization Immunization Schedules Malaria MMWR Morbidity & Mortality Weekly Report Outbreaks Pneumococcal Conjugate Vaccine for children Salmonella Source Type: news

Nigeria: Nigeria Launches Campaign to Protect More Than 28 Million Children Against Measles and Meningitis
[WHO] Children in 19 Northern states to be vaccinated in largescale campaign implemented by the Government of Nigeria and WHO with Gavi support (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 16, 2019 Category: African Health Source Type: news

Dangerous legacy of vaccine myths as one in three children have missed potentially lifesaving jabs
A total of 30 per cent of parents surveyed said their children had missed one or more routine jabs including MMR, flu or meningitis. One in four claimed this is for 'safety concerns' about vaccines. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2019 Category: Consumer Health News Source Type: news

Nigeria: Over 2 Million Children to Be Vaccinated
[This Day] Over 2 million children in Benue State are to be vaccinated during the 2019 integrated measles and meningitis campaign to hold from 16th to 23rd November, 2019 in the 277 wards across the 23 local government areas of Benue State. Executive Secretary, State Primary Health Care Board, Dr. Bem Ageda disclosed this during a media orientation meeting in Makurdi yesterday saying that both measles and meningitis immunisations so were to run concurrently. Ageda said a total of 1,108,990 children between the ages o (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 9, 2019 Category: African Health Source Type: news

Vaccine update: issue 300, October 2019, bug special edition
Topics covered include the Vaccine Evaluation unit, shortage of pneumococcal polysaccharide vaccine (PPV23), vaccination of individuals with uncertain or incomplete immunisation status, vaccine supply for non-routine programme and vaccine supply for 2019 to 2020 Flu programme. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 1, 2019 Category: Consumer Health News Source Type: news

AAFP Query Prompts CMS Order on Pneumococcal Vaccine Denial
In response to AAFP concerns that some physicians'Medicare claims for administering pneumococcal vaccinations have been denied, CMS has instructed Medicare contractors to cease local pneumococcal vaccination frequency edits. (Source: AAFP News)
Source: AAFP News - October 16, 2019 Category: Primary Care Source Type: news

Effect of Pneumococcal Conjugate Vaccines on Meningitis Effect of Pneumococcal Conjugate Vaccines on Meningitis
Did the introduction of pneumococcal conjugate vaccines help decrease the incidence of pneumococcal meningitis?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2019 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 201318
Prospective cohort study (n=2,934) found that the incidence of pneumococcal community acquired pneumonia increased from 32.2 to 48.2 per 100 000 population, predominantly due to non-vaccine type serotype and serotype 3. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 10, 2019 Category: Consumer Health News Source Type: news

The Toll Mounts From a Mystery Disease Some Call “The New Polio”
Carter Roberts’ motorized wheelchair didn’t arrive until the day he died. It had been a long time coming and his parents had fought hard to get it. The chair cost more than $32,000 and the insurance companies wouldn’t cover it, so the family went to court. One insurer eventually agreed to pay for some components of the chair but not the whole thing. And then none of it mattered anyway. On Sept. 22, 2018, the Roberts’ doorbell rang and the chair was delivered. Also on Sept. 22, 2018, Carter died, just three months shy of his sixth birthday. He had been largely paralyzed for the final two years of his...
Source: TIME: Health - October 9, 2019 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Infectious Disease viruses Source Type: news

Survey: Many U.S. Adults Not Planning to Get Flu Vaccine
Vaccine knowledge and anticipated rates of vaccination even lower for pneumococcal disease (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 4, 2019 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, Oncology, Pathology, Pediatrics, Pharmacy, Pulmonology, Rheumatology, Institutional, Source Type: news

Pneumococcal vaccines cost  effective in elderly
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2019 Category: Drugs & Pharmacology Source Type: news

Meningitis B is rare but deadly. Parents who lost children to the disease wonder why no one mentioned a vaccine.
CDC guidelines leave it up to physicians to talk about the optional vaccine. But not all doctors do. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 16, 2019 Category: Consumer Health News Authors: Sarah Elizabeth Richards Source Type: news

Double meningitis amputee pleads for university students to get their jab ahead of freshers' week
Mike Chinchen, 50, from Bournemouth lost his legs after the deadly infection poisoned his blood and cut off circulation to his limbs. He hopes students get vaccinated before the new semester. (Source: the Mail online | Health)
Source: the Mail online | Health - September 16, 2019 Category: Consumer Health News Source Type: news

Vaccination Coverage Among US Adolescents Aged 13-17 Vaccination Coverage Among US Adolescents Aged 13-17
This report surveyed vaccination coverage among adolescents in the United States, with a special emphasis on HPV vaccine and meningococcal vaccine.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Hundreds of Detained Migrants Diagnosed With Mumps in 19 States
Mumps has swept through 57 immigration detention facilities in 19 states since September, according to the first U.S. government report on the outbreaks in the overloaded immigration system. The virus sickened 898 adult migrants and 33 detention center staffers, the Centers for Disease Control and Prevention said in its report Thursday. New cases continue as migrants are taken into custody or transferred between facilities, the report said. As of last week, outbreaks were happening in 15 facilities in seven states. In response to the report, Immigration and Customs Enforcement spokesman Bryan Cox said medical professionals...
Source: TIME: Health - August 29, 2019 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Immigration onetime Source Type: news

Eritrea: Sawa - Seminar On Health Issues
[Shabait] Sawa -Seminar on the control and prevention of communicable diseases in general and that of meningitis vaccination program that is set to be conducted on the coming months of November and December was organized to the staff members of the Sawa National Military Training Center. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2019 Category: African Health Source Type: news

Adult Pneumococcal Vaccine: Who Needs It? When and Why?
The rules for pneumococcal vaccination can seem a little arbitrary. See what you know about the ACIP rationale behind these 5 recommendations for PCV13 and PPSV23. (Source: ConsultantLive)
Source: ConsultantLive - August 20, 2019 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Immunization Immunization Awareness Month Vaccines Source Type: news

Nigeria: New Drug to Address Deadly Meningitis in Nigeria
[CAJ News] Abuja -Nigeria has introduced a new vaccine into its immunisation scheduled to curb the spread of meningitis that has left hundreds of people dead in recent months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 14, 2019 Category: African Health Source Type: news

Nigeria: Nigeria Introduces Meningitis a Conjugate Vaccine Into Routine Epi Schedule
[WHO] Abuja, 12 August, 2018 - Nigeria has introduced the Meningitis A Conjugate Vaccine into the routine Expanded Programme on Immunization (EPI) schedule. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 13, 2019 Category: African Health Source Type: news

Pneumococcal Vaccine Safe, Effective in Adults With Stable HIV Pneumococcal Vaccine Safe, Effective in Adults With Stable HIV
Pneumococcal vaccination is safe and effective in people with HIV who are stable on antiretroviral therapy (ART), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 7, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Adult pneumococcal vaccination in US: uptake program favoured
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2019 Category: Drugs & Pharmacology Source Type: news

Maine Confirmed Its First Case of a Rare Tick-Borne Virus in Years. Here ’s What to Know About Powassan
Health officials have confirmed that an individual in Maine is sick with Powassan virus disease, marking the first time since 2017 that a person in the state has come down with the rare and serious tick-borne illness. The Maine Center for Disease Control and Prevention announced Wednesday that a southern Maine resident was hospitalized for Powassan encephalitis—brain inflammation associated with the virus—after showing symptoms in late June. The announcement did not specify the individual’s current condition, but health officils doctors to stay vigilant about the potential spread of Powassan throughout th...
Source: TIME: Health - July 25, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Maine onetime Source Type: news

GSK lifts outlook after vaccines drive strong quarter
Shingles and meningitis treatments help offset blow from generic version of key drug (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 24, 2019 Category: Pharmaceuticals Source Type: news

ACIP Approves New Guidance on HPV, Pneumococcal Vaccines
During the June 26-27 meeting of the CDC's Advisory Committee on Immunization Practices, the group voted to update its recommendations for use of the nine-valent HPV and 13-valent pneumococcal conjugate vaccines. (Source: AAFP News)
Source: AAFP News - July 3, 2019 Category: Primary Care Source Type: news

An improved vaccine for bacterial meningitis and bloodstream infections
(American Society for Microbiology) Researchers have now developed a new vaccine, a native outer membrane vesicle (NOMV) vaccine, for meningitis and bloodstream infections caused by 'meningococcal group B' bacteria. This will allow younger people to be vaccinated and will address several limitations of the current vaccinations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2019 Category: International Medicine & Public Health Source Type: news

Kenya: Ministry in Bid to Curb Meningitis With New Vaccine
[Nation] The Health ministry has launched a new vaccine meant to protect people against meningitis A in five target counties as part of routine immunisation. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 27, 2019 Category: African Health Source Type: news

US vaccine panel downgrades pneumonia shot recommendation
A federal scientific panel on Wednesday downgraded its recommendation that retirement-age Americans get a top-selling vaccination against a bacteria that can cause pneumonia, meningitis and other illnesses (Source: ABC News: Health)
Source: ABC News: Health - June 26, 2019 Category: Consumer Health News Tags: Health Source Type: news

Pneumococcal Conjugate Vaccine in Infancy Cuts Otitis Media Pneumococcal Conjugate Vaccine in Infancy Cuts Otitis Media
Administration of pneumococcal conjugate vaccine (PCV) in early infancy substantially reduces the risk of pneumococcal acute otitis media (AOM), according to a new Cochrane review.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2019 Category: Consumer Health News Tags: Pediatrics News Source Type: news